Dermatology
Spindle Cell Lipoma
Are You Confident of the Diagnosis?
What you should be alert for in the history
Lesions are typically seen in adults.
Characteristic findings on physical examination
Characteristic finding is a low-growing asymptomatic soft subcutaneous solitary nodule, most commonly in the subcutaneous tissue of the posterior neck, shoulder, and back.
Expected results of diagnostic studies
Histopathology demonstrates an accumulation of normal-appearing mature adipose intermixed with spindle cells (
Figure 1.
Spindle cell lipoma (H&E). (Courtesy of Cloyce L. Stetson, MD)
Figure 2.
Spindle cell lipoma (H&E). (Courtesy of Cloyce L. Stetson, MD)
Computed tomagraphy (CT) scans reveal homogenous low-density areas, intermixed with higher density areas, which correlate with spindle cells accumulations. Magnetic resonance imaging (MRI) yields a better tissue deliniation and extent of the tumor.
Diagnosis confirmation
Classic lipomas are not otherwise histologically associated with the accumulation of spindle cells.
Epidermal inclusion cysts demonstrate an overlying punctum, are less stable in size, and are histologically distinct.
Pilar cysts are usually on the scalp, presenting as marble-like nodules that histologically distinct.
Angioleiomyomas are histologically distinct, as are subcutaneous neurofibromas, subcutaneous dermatofibromas, neurilemmomas, rheumatoid nodules (associated with rheumatic disease), pseudorheumatoid nodule/deep granulare annulare, subcutaneous sarcoidosis, abscesses, and hematomas (usually associated with trauma).
Who is at Risk for Developing this Disease?
The typical patient is a 45- to 65-year-old male (the latter in about 91% of cases)
What is the Cause of the Disease?
Etiology
Pathophysiology
Lesions result from an accumulation of spindle cells, with or without fat accumulation, associated with chromosomal rearrangements of 13q and 16q.
Systemic Implications and Complications
Occasionally, spindle cell lipomas may be in unusual areas. An esophageal spindle cell lipoma has been reported to result in dysphagia, weight loss, and near asphyxiation when the pedunculated mass was aspirated.
Treatment Options
Surgical excision
Optimal Therapeutic Approach for this Disease
If treatment is desired, surgical excision is the optimal treatment.
Patient Management
Reassure the patient that these are benign lesions that can be excised if desired.
Unusual Clinical Scenarios to Consider in Patient Management
There is a concern that some cases of pleomorphic lipoma (pseudosarcomatous variant of spindle cell lipoma) may actually represent liposarcoma, especially if situated deep in tissue (
Figure 3.
Pleomorphic lipoma (H&E). (Courtesy of Cloyce Stetson, MD)
What is the Evidence?
Pandya, KA, Radke, F. "Benign skin lesions: lipomas, epidermal inclusion cysts, muscle and nerve biopsies". Surg Clin N Am. vol. 89. 2009. pp. 677-87.
(Review of lipoma and epidermal inclusion cysts, including workup and treatment)Bancroft, LW, Kransdorf, MJ, Peterson, JJ, O’Conner, MI. "Benign fatty tumors: classification, clinical course, imaging appearance, and treatment". Skeletal Radiol. vol. 35. 2006. pp. 719-33.
(Review of different fatty tumors, with special discussion of imaging findings)Azzopardi, JG, Iocco, J, Salm, R. "Pleomorphic lipoma: a tumour simulating liposarcoma". Histopathology. vol. 7. 1983. pp. 511-23.
(Review of pleomorphic lipoma)Copyright © 2017, 2012 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Sign Up for Free e-newsletters
ONA Articles
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
Bone Cancer | Regimens | Drugs |
Brain Cancer | Regimens | Drugs |
Breast Cancer | Regimens | Drugs |
Endocrine Cancer | Regimens | Drugs |
Gastrointestinal Cancer | Regimens | Drugs |
Genitourinary Cancer | Regimens | Drugs |
Gynecologic Cancer | Regimens | Drugs |
Head and Neck Cancer | Regimens | Drugs |
Hematologic Cancer | Regimens | Drugs |
Lung Cancer | Regimens | Drugs |
Other Cancers | Regimens | |
Rare Cancers | Regimens | |
Skin Cancer | Regimens | Drugs |